摘要
The development of new HIV nonnucleoside reverse transcriptase inhibitors (NNRTIs) offers the possibility of generating structures of increased potency. On this basis, a series of 5-alkylsulfanyl and 5-(4'-arylsulfonyl)piperazine derivatives of 1-phenyl-2-alkyl-4-nitroimidazoles 5-21 was synthesized with the aim to develop new NNRTIs. The new synthesized compounds were assayed against HIV-1 and HIV-2 in MT-4 cells. Compounds 9 and 13, with an alkyl-sulfanyl group at C-5 of the 4-nitroimidazole backbone, showed inhibition of HIV-1 with EC50 4.04 mu g/mL and 2.37 mu g/mL, and therapeutic indexes (SI) of 17 and 13, respectively.
- 出版日期2007
- 单位河北医科大学